How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

A

NYSE:A
Get a brief AI stock analysisSaves ~ 15 minutes of your time

A

Agilent Technologies IncNYSE A Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNYS - New York Stock Exchange, Inc

FAIR VALUE

Is A undervalued compared to its fair value?

The fair value of A stock is hidden USD. Relative to the market price of 131.78 USD Agilent Technologies Inc is hidden.

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently emp...[More about valuation]

Agilent Technologies Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

38.504 $B

Price:

131.78 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

1.051

A stock is better priced for investment 44% of the companies in Healthсare sector
A stock is better priced for investment 61% of the companies on New York Stock Exchange, Inc Exchange

FINANCIALS

Agilent Technologies financial for reporting period

Income Statement

1.6 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.31 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

1.6 B 100%
0.86 B 54%
0.31 B 20%

Balance Sheet

10.9 B
6.2 B

Financial Position Analysis

Assets

10.9 B
Current Assets
4.2 B
Total non-current assets
6.7 B

Total current liabilities
2 B
Total non-current liabilities
2.7 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.33 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Agilent Technologies fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

21 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
15 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
11 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is A attractive for investment based on fundamental analysis?

A stock rating is hidden. Agilent Technologies is a hidden by Eyestock methodology.

Get A Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

19

Gross Margin:

51

CFO / Debt ratio:

hidden

Current ratio:

2.415

Debt / Equity ratio:

0.447

ROE:

21

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

A analysis by AI

Was this information helpful?

Eyebot AI analysis

Agilent Technologies Inc is a company in the health-care sector that has shown consistent growth in its financial performance over the past four quarters. The company has maintained a strong gross margin, indicating efficient cost management, and a healthy current ratio, reflecting solid liquidity position. Additionally, the return on equity has been stable and above industry benchmarks, suggesting effective capital utilization. However, there are some areas of concern. The net profit margin has been fluctuating, which may indicate potential challenges in managing operational expenses. The company's stability ratios over the past few quarters have been below the expected benchmarks, raising questions about the company's long-term sustainability and growth prospects. Furthermore, the company's price-to-earnings (P/E) ratio has been consistently high, suggesting that the stock may be overvalued relative to its earnings potential. Investors should carefully assess these factors before making any investment decisions in Agilent Technologies Inc.

Agilent Technologies Inc competitors

TM

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, an...

Discover

DH

DHR

Danaher Corp

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company is headqu...

Discover

LO

LONN.SW

Lonza Group AG

Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt. The company went IPO on 2002-0...

Discover

Agilent Technologies Inc dividends

Agilent Technologies Inc dividend yield is 0.73%

The annual dividend is 0.93 USD

A dividend metrics

Payout ratio
22.13%
Dividend yield
0.73%
Annual dividend
0.93
Dividend streak
11 years
Average dividend yield over 3 years
0.84%
Average dividend yield over 5 years
0.81%

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About A stock

About the company Agilent Technologies Inc

Market cap $B

38.504

Dividend yield

0.73 %

Shares outstanding

295.702 B

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,300 full-time employees. The company operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.

A profile

  • Ticker

    A

  • Country

    USA

  • Exchange

    XNYS - New York Stock Exchange, Inc

  • Report currency

    USD - US dollar

  • IPO date

    18 November 1999

  • Sector

    Healthсare

  • Industry

    Life Sciences Tools & Services

  • Employees

    18300

  • City

    Santa Clara

  • Address

    5301 Stevens Creek Blvd

  • Cusip

    00846U101